Principles and Practice of Psychopharmacotherapy"Fully updated for its Fifth Edition, Principles and Practice of Psychopharmacotherapy summarizes the latest data on hundreds of drug and device-based therapies and offers practical, evidence-based guidelines and treatment strategies for virtually every psychiatric disorder. Highlights of this edition include expanded coverage of pharmacogenomics, updates on treatments for elderly patients, and discussion of mechanisms of action for drugs used in sleep disorders, especially narcolepsy"--Provided by publisher. |
Contents
Cohen D Taieb O Flament M et al Absence of 133 Rasmussen KG Jarvis MR Zorumski CF Ketamine | 217 |
PRINCIPLES AND PRACTICE OF PSYCHOPHARMACOTHERAPY | iii |
39 | 20 |
McDonald WM Phillips VL Figiel GS et al Cost and methohexital as anesthetic agents for electrocon | 115 |
Milstein V Small JG Klapper MH et al Unilateral ver rons are damaged by caffeineaugmented electroshock | 121 |
Folk JW Kellner CH Beale MD et al Anesthesia for 148 Jacobsen FM Risperidone in the treatment of affective | 127 |
preliminary | 153 |
Price TR McAllister TW Response of depressed pa 182 Richelson E Mechanisms of action of repetitive transcra | 162 |
a controlled investigation | 168 |
Swartz CM Anesthesia for ECT Convuls Ther 1993 149 Masiar SJ Johns CA ECT following clozapine Br | 659 |
Other editions - View all
Common terms and phrases
activity acute adverse effects affective disorder agents alcohol alprazolam antidepressant antipsychotic anxiety disorder Arch Gen Psychiatry ARIP associated behavior benzodiazepine Biol Psychiatry bipolar disorder bupropion Chapter chronic Clin Psychiatry Clin Psychopharmacol clozapine cognitive comorbid compared controlled trial decrease depressed patients depressive disorder discontinuation dose double-blind drug duloxetine efficacy episode FGAs fluoxetine haloperidol HPDL imipramine improvement increased insomnia interactions Janicak PG lithium long-term lorazepam major depression mania manic MAOIs medication ment meta-analysis metabolism metabolites mg/day monotherapy mood disorders mood stabilizers nefazodone olanzapine onset outcome panic disorder paroxetine pharmacokinetics placebo placebo-controlled trial plasma levels potential PRACTICE OF PSYCHOPHARMACOTHERAPY PRINCIPLES AND PRACTICE psychosis psychotic quetiapine randomized receptor relapse reported response risk RISP risperidone schizophrenia seizures serotonin sertraline SGAs sleep SSRIs strategy suicide superior to placebo symptoms syndrome TCAs therapeutic therapy tion treat treatment venlafaxine verapamil weeks withdrawal